Swedbank AB Sells 73,126 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Swedbank AB lessened its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 43.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 95,692 shares of the company’s stock after selling 73,126 shares during the period. Swedbank AB owned about 0.17% of Molina Healthcare worth $27,851,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Forsta AP Fonden grew its holdings in shares of Molina Healthcare by 3.4% during the 4th quarter. Forsta AP Fonden now owns 12,300 shares of the company’s stock valued at $3,580,000 after purchasing an additional 400 shares during the last quarter. R Squared Ltd bought a new stake in shares of Molina Healthcare during the fourth quarter worth $114,000. KBC Group NV grew its stake in shares of Molina Healthcare by 14.6% during the fourth quarter. KBC Group NV now owns 125,486 shares of the company’s stock worth $36,522,000 after buying an additional 15,993 shares during the last quarter. Blue Trust Inc. increased its holdings in shares of Molina Healthcare by 35.5% during the fourth quarter. Blue Trust Inc. now owns 649 shares of the company’s stock worth $189,000 after buying an additional 170 shares in the last quarter. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its stake in shares of Molina Healthcare by 18.8% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 4,517 shares of the company’s stock valued at $1,315,000 after acquiring an additional 715 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Wall Street Analyst Weigh In

MOH has been the topic of a number of research reports. StockNews.com upgraded Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. Truist Financial lowered their price objective on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research report on Thursday, October 24th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $350.00 target price (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Finally, Robert W. Baird cut their price target on shares of Molina Healthcare from $405.00 to $331.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Molina Healthcare has an average rating of “Hold” and a consensus target price of $359.18.

Molina Healthcare Stock Performance

MOH stock opened at $313.26 on Friday. The company has a current ratio of 1.54, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53. Molina Healthcare, Inc. has a 1-year low of $272.69 and a 1-year high of $423.92. The stock has a 50-day moving average price of $297.05 and a 200-day moving average price of $317.54. The firm has a market cap of $17.92 billion, a PE ratio of 15.91, a price-to-earnings-growth ratio of 0.94 and a beta of 0.54.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.